| Parameter |
SAS (n=2,726) |
FAS (n=1,537) |
| Age, years (mean ± SD) |
70.6 ±10.4 |
71.0 ± 10.2 |
| Gender, n (%) |
|
|
| Male |
1,706 (62.6%) |
974 (63.4%) |
| Female |
1,013 (37.2%) |
558 (36.3) |
| Missing |
7 (0.3%) |
5 (0.3%) |
| Diagnosis of CHD, n (%) |
|
|
| Yes |
2,206 (80.9%) |
1,266 (82.4%) |
| No |
287 (10.5%) |
152 (9.9%) |
| Missing |
233 (8.6%) |
119 (7.7%) |
| Revascularisation therapy, n (%) |
1,435 (52.6%) |
826 (53.7%) |
| Stent |
1,234 (52.5%) |
721 (51.2%) |
| Balloon dilatation |
662 (28.2%) |
421 (29.9%) |
| Coronary bypass surgery |
455 (19.4%) |
264 (18.8%) |
| Disease duration, n (%) |
|
|
| ≤6 months |
|
404 (26.3%) |
| >6 to ≤12 months |
|
161 (10.5%) |
| >1 to ≤2 years |
|
194 (12.6%) |
| >2 to ≤3 years |
|
163 (10.6%) |
| >3 to ≤4 years |
|
124 (8.1%) |
| >4 to ≤5 years |
|
92 (6.0%) |
| >5 years |
|
399 (26.0%) |
|
